Clinuvel Pharmaceuticals Limited · ASX:CUV

Clinuvel Pharmaceuticals — Shareholder Meeting (November 2008)

12 slides from Clinuvel Pharmaceuticals's shareholder meeting presentation, Nov 13, 2008

  1. Slide 1: Photoprotection - Afamelanotide 16mg

    For personal use only Photoprotection Afamelanotide 16mg ASX: CUV XETRA-DAX: UR9 ADR 1: CLVLY

  2. Slide 2: Forward-looking statements

    Clinuvel is an Australian biopharmaceutical company focused on For personal use only developing its leading drug candidate, afamelanotide, for a range of UV- related skin disorders resulting from exposure of the skin to harmful UV radiation. Pharmaceutical research and development involves long lead

  3. Slide 3: Our journey/strategy

    For personal use only Our journey/strategy

  4. Slide 4: Clinuvel's Domain: Photoprotection

    Clinuvel's Domain:.Photoprotection Macro Markets a Market US$500M @QDD: First entry to market leadership mpetitive environment | Risk Micro Markets @) \ elanotide, preventative rst in class drug for phototoxicity (skin diseases) ox Organ Transplant Recipients uw Erythropoietic Protoporphyria »High d

  5. Slide 5: Milestones

    w$ anv deo yaxIeW ee x? Na 4 ca & SS» & e S LS le \ _« 2 & SP YM SS » < a Se .& SSF FE SE & SX sf wv wer ME Milestones Na fia i tr? Ff n i S> al mu T al T pi e T A T Ee ee wy oS Yr & ——| s we < « RS Ss ? Oo Re & Ros Ra oP se oS PUP SS KS & @ & SS Ss eS a ee & Re) OS cS Poe RN eS Ss os & S$ < s Rs RS

  6. Slide 6: Positioning CUV

    For personal use only Positioning CUV

  7. Slide 7: Quantitative Analysis Clinuvel

    Quantitative Analysis Clinuvel SS “© Technological/ © Clinical Business Acid Test FOr personal use Ps) ® © = D - 3 < 2005 2007 2009 Safety in animals, toxicology SDT/MDT | 1 = | 2 — Safety in humans, SDT [ya “1 Te 4 1/1 e| Vv Formulation ST, possible 4 CMC SISISIS | Manufacturing, tech, scale, COGS

  8. Slide 8: Quantitative Analysis Clinuvel

    FOr personal use only Quantitative Analysis Clinuvel Score x —eT/C —m— Reg —#— Bus —— Acid =—— Total —— Total TD

  9. Slide 9: Market score

    For personal use only • Market score

  10. Slide 10: Final market image

    fina For personal use only • Final market image

  11. Slide 11: Photoprotection

    For personal use only Photoprotection ASX: CUV XETRA-DAX: UR9 ADR 1: CLVLY

  12. Slide 12: Much, much appreciation to…

    Much, much appreciation to…. For personal use only Emily, Caroline, Darren, Judith, Dennis, Nicoletta, Lachlan, Lee, Nick, Sonyia, Sumith, Jessica, Colin, Nicole, Mahir, Daniela, Theoman, Kate, David, Celia, Chris, Martina, Linda, Hank, Brenda, Roger, Stan, Jack, and…ChrisV, Rudi, and Anton, and Deb

Clinuvel Pharmaceuticals — Shareholder Meeting (November 2008) on 6ix